CID 16186601

Peptide derived from ccr5 n-terminal fused to the fc region of human igg1

Structural Information

Molecular Formula
C117H170N26O53S5
SMILES
CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)OS(=O)(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CC=C(C=C2)OS(=O)(=O)O)C(=O)N[C@@H](CC3=CC=C(C=C3)OS(=O)(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]5CCCN5C(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC6=CC=C(C=C6)OS(=O)(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)N
InChI
InChI=1S/C117H170N26O53S5/c1-9-57(5)93(112(174)133-77(49-88(122)151)102(164)128-74(46-61-20-28-65(29-21-61)194-199(184,185)186)100(162)130-76(48-63-24-32-67(33-25-63)196-201(190,191)192)104(166)141-95(59(7)148)114(176)136-81(53-145)107(169)125-71(36-39-89(152)153)115(177)142-42-13-16-84(142)109(171)134-80(52-144)106(168)124-69(34-37-86(120)149)97(159)126-72(117(179)180)15-11-12-41-118)139-105(167)79(51-91(156)157)131-101(163)75(47-62-22-30-66(31-23-62)195-200(187,188)189)132-113(175)94(58(6)10-2)140-110(172)85-17-14-43-143(85)116(178)83(55-147)137-108(170)82(54-146)135-111(173)92(56(3)4)138-98(160)70(35-38-87(121)150)123-99(161)73(45-60-18-26-64(27-19-60)193-198(181,182)183)129-103(165)78(50-90(154)155)127-96(158)68(119)40-44-197-8/h18-33,56-59,68-85,92-95,144-148H,9-17,34-55,118-119H2,1-8H3,(H2,120,149)(H2,121,150)(H2,122,151)(H,123,161)(H,124,168)(H,125,169)(H,126,159)(H,127,158)(H,128,164)(H,129,165)(H,130,162)(H,131,163)(H,132,175)(H,133,174)(H,134,171)(H,135,173)(H,136,176)(H,137,170)(H,138,160)(H,139,167)(H,140,172)(H,141,166)(H,152,153)(H,154,155)(H,156,157)(H,179,180)(H,181,182,183)(H,184,185,186)(H,187,188,189)(H,190,191,192)/t57-,58-,59+,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,92-,93-,94-,95-/m0/s1
InChIKey
VXFGCOUQXNMONK-FJSLEGQWSA-N
Compound name
(2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-carboxypropanoyl]amino]-3-(4-sulfooxyphenyl)propanoyl]amino]-5-oxopentanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoyl]amino]-3-(4-sulfooxyphenyl)propanoyl]amino]-3-carboxypropanoyl]amino]-3-methylpentanoyl]amino]-4-oxobutanoyl]amino]-3-(4-sulfooxyphenyl)propanoyl]amino]-3-(4-sulfooxyphenyl)propanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-4-carboxybutanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

2947.001 Da
Monoisotopic Mass

-14.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2948.0083 465.4
[M+Na]+ 2969.9902 449.2
[M-H]- 2945.9937 466.4
[M+NH4]+ 2965.0348 454.1
[M+K]+ 2985.9642 447.8
[M+H-H2O]+ 2929.9983 441.4
[M+HCOO]- 2991.9992 448.5
[M+CH3COO]- 3006.0149 444.2
[M+Na-2H]- 2967.9757 465.4
[M]+ 2947.0005 402.3
[M]- 2947.0015 402.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.